In vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: Identifying sinensetin as a novel antiangiogenesis agent

Molecular Nutrition and Food Research

Volumn 56, Issue 6, 2012, Pages 945-956

  Lam, In Kei ^a   Alex, Deepa ^a   Wang, You Hua ^b   Liu, Ping ^a,c   Liu, Ai Lin ^a,c   Du, Guan Hua ^c   Yuen Lee, Simon Ming ^a,d  

^a University of Macau   (Macao)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

^d UNIVERSITY OF MACAU   (Macao)

Author keywords

Angiogenesis; Polymethoxylated flavonoid; Sinensetin; Structure activity relationship; Zebrafish

Indexed keywords

EID: 84862526674     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100680     Document Type: Article

References (39)

1. Franco, C. A., Liebner, S., Gerhardt, H., Vascular morphogenesis: a Wnt for every vessel? Curr. Opin. Genet. Dev. 2009, 19, 476-483.
2. Gordon, M. S., Mendelson, D. S., Kato, G., Tumor angiogenesis and novel antiangiogenic strategies. Int. J. Cancer 2010, 126, 1777-1787.
3. Heidenreich, R., Rocken, M., Ghoreschi, K., Angiogenesis drives psoriasis pathogenesis. Int. J. Exp. Pathol. 2009, 90, 232-248.
4. Detoraki, A., Granata, F., Staibano, S., Rossi, F. W., et al., Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy 2010, 65, 946-958.
5. Jackson, J. R., Seed, M. P., Kircher, C. H., Willoughby, D. A., et al., The codependence of angiogenesis and chronic inflammation. FASEB J 1997, 11, 457-465.
6. Alex, D., Leong, E. C., Zhang, Z. J., Yan, G. T., et al., Resveratrol derivative, trans-3, 5, 4'-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation. J. Cell. Biochem. 2010, 109, 339-346.
7. Alex, D., Lam, I. K., Lin, Z., Lee, S. M., Indirubin shows anti-angiogenic activity in an in vivo zebrafish model and an in vitro HUVEC model. J. Ethnopharmacol. 2010, 131, 242-247.
8. Tang, J. Y., Li, S., Li, Z. H., Zhang, Z. J., et al., Calycosin promotes angiogenesis involving estrogen receptor and mitogen-activated protein kinase (MAPK) signaling pathway in zebrafish and HUVEC. PLoS One 2010, 5, e11822.
9. Perez-Vizcaino, F., Duarte, J., Flavonols and cardiovascular disease. Mol. Aspects Med. 2010, 31, 478-494.
10. Benavente-Garcia, O., Castillo, J., Alcaraz, M., Vicente, V., et al., Beneficial action of citrus flavonoids on multiple cancer-related biological pathways. Curr. Cancer Drug Targets 2007, 7, 795-809.
11. Benavente-Garcia, O., Castillo, J., Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food. Chem. 2008, 56, 6185-6205.
12. Walle, T., Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin. Cancer Biol. 2007, 17, 354-362.
13. Miyamoto, S., Yasui, Y., Ohigashi, H., Tanaka, T., et al., Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem. Biol. Interact. 2010, 183, 276-283.
14. Miyamoto, S., Yasui, Y., Tanaka, T., Ohigashi, H., et al., Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis 2008, 29, 1057-1063.
15. Murakami, A., Nakamura, Y., Torikai, K., Tanaka, T., et al., Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res. 2000, 60, 5059-5066.
16. Tang, M. X., Ogawa, K., Asamoto, M., Chewonarin, T., et al., Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr. Cancer 2011, 63, 227-233.
17. Luo, G., Guan, X., Zhou, L., Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer. Biol. Ther. 2008, 7, 966-973.
18. Chen, K. H., Weng, M. S., Lin, J. K., Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem. Pharmacol. 2007, 73, 215-227.
19. Ohnishi, H., Asamoto, M., Tujimura, K., Hokaiwado, N., et al., Inhibition of cell proliferation by nobiletin, a dietary phytochemical, associated with apoptosis and characteristic gene expression, but lack of effect on early rat hepatocarcinogenesis in vivo. Cancer Sci. 2004, 95, 936-942.
20. Lam, K. H., Alex, D., Lam, I. K., Tsui, S. K., et al., Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model. J. Cell. Biochem. 2011, 112, 3313-3321.
21. Kunimasa, K., Ikekita, M., Sato, M., Ohta, T., et al., Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo. Cancer Sci. 2010, 101, 2462-2469.
22. Langheinrich, U., Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003, 25, 904-912.
23. Tran, T. C., Sneed, B., Haider, J., Blavo, D., et al., Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res. 2007, 67, 11386-11392.
24. Lawson, N. D., Weinstein, B. M., In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 2002, 248, 307-318.
25. Westerfield, M., (Ed.) THE ZEBRAFISH BOOK; A guide for the laboratory use of zebrafish (Danio rerio), University of Oregon Press, Eugene 2007.
26. Hong, S. J., Wan, J. B., Zhang, Y., Hu, G., et al., Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo. Phytother. Res. 2009, 23, 677-686.
27. Green, C. O., Wheatley, A. O., Osagie, A. U., St, A. M. E., et al., Determination of polymethoxylated flavones in peels of selected Jamaican and Mexican citrus (Citrus spp.) cultivars by high-performance liquid chromatography. Biomed. Chromatogr. 2007, 21, 48-54.
28. Loon, Y. H., Wong, J. W., Yap, S. P., Yuen, K. H., Determination of flavonoids from Orthosiphon stamineus in plasma using a simple HPLC method with ultraviolet detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 816, 161-166.
29. Singh, S. P., Wahajuddin, Tewari, D., Patel, K., et al., Permeability determination and pharmacokinetic study of nobiletin in rat plasma and brain by validated high-performance liquid chromatography method. Fitoterapia 2011, 82, 1206-1214.
30. Saigusa, D., Shibuya, M., Jinno, D., Yamakoshi, H., et al., High-performance liquid chromatography with photodiode array detection for determination of nobiletin content in the brain and serum of mice administrated the natural compound. Anal. Bioanal. Chem. 2011, 400, 3635-3641.
31. Yang, C. S., Lambert, J. D., Sang, S., Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch. Toxicol. 2009, 83, 11-21.
32. Sun, C. L., Yuan, J. M., Koh, W. P., Yu, M. C., Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006, 27, 1310-1315.
33. Ui, A., Kuriyama, S., Kakizaki, M., Sone, T., et al., Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes Control 2009 20, 1939-1945.
34. Tang, N., Wu, Y., Zhou, B., Wang, B., et al., Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 2009, 65, 274-283.
35. Lee, M. J., Maliakal, P., Chen, L., Meng, X., et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1025-1032.
36. Lai, C. S., Tsai, M. L., Cheng, A. C., Li, S., et al., Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane-treated mice. Mol. Nutr. Food Res. 2011, 55, 278-290.
37. Rihel, J., Prober, D. A., Arvanites, A., Lam, K., et al., Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327, 348-351.
38. Zhu, Y., Zhu, X., Wu, G., Ma, Y., et al., Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure-activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids. J. Med. Chem. 2010, 53, 1990-1999.
39. Hao, J., Ho, J. N., Lewis, J. A., Karim, K. A., et al., In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 2010, 5, 245-253.